StartseitePodcastsThe Long Run with Luke TimmermanEp201: Jeremy Levin on Biotech in the BalanceThe Long Run with Luke TimmermanEp201: Jeremy Levin on Biotech in the Balance19.05.2026 · 1 Std. 9 Min.Folge abspielenAb dieser Stelle teilenShownotesJeremy Levin, executive chair of Ovid Therapeutics, discusses his new book "Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust."Alle Folgen von The Long Run with Luke Timmerman